Financial Ratios

IND-SWIFT LABORATORIES LTD.

NSE : INDSWFTLABBSE : 532305ISIN CODE : INE915B01019Industry : Pharmaceuticals & DrugsHouse : Private
BSE116.48-4.53 (-3.74 %)
PREV CLOSE ( ) 121.01
OPEN PRICE ( ) 122.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 47705
TODAY'S LOW / HIGH ( )115.50 124.10
52 WK LOW / HIGH ( )63.4 138.25
NSE116.55-4.3 (-3.56 %)
PREV CLOSE( ) 120.85
OPEN PRICE ( ) 122.50
BID PRICE (QTY) 116.55 (128)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 547465
TODAY'S LOW / HIGH( ) 115.10 124.00
52 WK LOW / HIGH ( )63 138.45
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)7.19-0.97-0.74-3.528.11
   CEPS(Rs)16.9021.2014.0311.7229.98
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)83.1473.6872.3070.8873.53
   Tax Rate(%)46.37171.41127.29-6.2734.53
Margin Ratios
   Core EBITDA Margin(%)19.1919.4220.9018.6717.21
   EBIT Margin(%)14.8110.3813.4711.5320.77
   Pre Tax Margin(%)6.840.801.87-2.598.10
   PAT Margin (%)3.67-0.57-0.51-2.755.30
   Cash Profit Margin (%)8.6312.569.609.1719.60
Performance Ratios
   ROA(%)2.42-0.33-0.25-1.152.07
   ROE(%)9.17-1.32-1.04-5.4112.12
   ROCE(%)12.677.478.246.0410.65
   Asset Turnover(x)0.660.570.490.420.39
   Sales/Fixed Asset(x)0.870.760.650.550.53
   Working Capital/Sales(x)1.601.461.491.411.53
Efficiency Ratios
   Fixed Capital/Sales(x)1.141.311.541.811.87
   Receivable days141.60151.57165.89173.48179.63
   Inventory Days132.72140.57147.38159.30158.87
   Payable days105.46105.24107.82116.97111.76
Valuation Parameters
   PER(x)7.680.000.000.004.84
   PCE(x)3.273.135.141.851.31
   Price/Book(x)0.660.901.000.310.53
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)1.011.331.621.491.76
   EV/Core EBITDA(x)4.545.576.836.317.39
   EV/EBIT(x)6.7712.7211.9612.848.42
   EV/CE(x)0.660.750.790.630.69
   M Cap / Sales0.280.400.500.170.26
Growth Ratio
   Net Sales Growth(%)16.5815.3513.933.78-0.54
   Core EBITDA Growth(%)8.1216.0114.942.8312.97
   EBIT Growth(%)65.50-10.9833.56-42.39136.40
   PAT Growth(%)843.92-29.8078.84-153.88118.90
   EPS Growth(%)843.96-29.8078.84-143.38108.35
Financial Stability Ratios
   Total Debt/Equity(x)1.722.142.282.383.18
   Current Ratio(x)3.063.183.022.732.39
   Quick Ratio(x)1.841.861.781.621.46
   Interest Cover(x)1.861.081.160.821.64
   Total Debt/Mcap(x)2.582.382.297.795.97

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.